This compound is used in Africa for intermittent preventive therapy in pregnant women (IPTp) and infants (IPTi). The resistance of some Plasmodium falciparum strains against a treatment with sulfadoxine pyrimethamine is due to the fact that resistant strains show a mutation in the genes Pfdhfr (P. falciparum dihydrofolate reductase) and Pfdhps (P. falciparum dihydropteroate synthase). These apparently progressing resistances endanger any mass treatment. In three foci of East Africa the populations are already fully resistant.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Readings
Naidoo I, Roper C (2013) Mapping partially resistant, fully resistant, and super resistant malaria. Trends Parasitol 29:505–515
Venkatesan M et al (2013) Monitoring antifolate resistance in intermittent preventive therapy for malaria. Trends Parasitol 29:497–504
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Mehlhorn, H. (2016). Sulfadoxine Pyrimethamine Resistance. In: Mehlhorn, H. (eds) Encyclopedia of Parasitology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-43978-4_4358
Download citation
DOI: https://doi.org/10.1007/978-3-662-43978-4_4358
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-43977-7
Online ISBN: 978-3-662-43978-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences